AI healthcare deals are roaring.
Digital health startups raised $14.2 billion in 2025, up 35% from 2024, with AI‑enabled companies capturing 54% of that capital and enjoying roughly a 19% premium on average deal size versus non‑AI peers, research from Rock Health details. Investors have rushed into ambient scribes, agentic triage tools, and “doctor‑copilot” platforms—including Abridge (an AI-powered clinical scribe) which raised about $550 million across two mega‑rounds in 2025.
